Search results
Pfizer agrees to settle 10K Zantac lawsuits, as GSK trial links heartburn drug to cancer
BenefitsPRO· 43 minutes agoPfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 1 day agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
UPDATE 1-Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
Reuters via Yahoo Finance· 1 day agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing ...
Pfizer to Settle 10K Lawsuits Over Drug Linked to Cancer, Costing Company Millions
IJR· 5 hours agoBig Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 4 hours agoWhich dividend stocks are worth buying in the current market? Telecom giant AT&T (NYSE: T) and pharmaceutical titan Pfizer (NYSE: PFE) scan as incredible...
Young Patient Dies After Receiving Pfizer Gene Therapy
Futurism via Yahoo News· 3 hours agoTragedy has struck during an important Pfizer medical trial when a young boy suffered a fatal sudden...
Pfizer Inc's Dividend Analysis
Guru Focus· 1 day agoPfizer Inc (PFE, Financial) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors look forward ...
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...
Benzinga via Yahoo Finance· 21 hours agoA young patient died due to cardiac arrest after receiving Pfizer Inc’s (NYSE:PFE) experimental gene...
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Motley Fool via Yahoo Finance· 8 hours agoAfter steadily raising its payout by 163% over the past 15 years, Pfizer (NYSE: PFE) continues to be...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...